Fitch Ratings Fitch Rates Abbott Notes Offering at A(EXP) The ratings agency also assigned a Negative Rating Watch to the firm's notes offering, noting it will resolve this notation as more details of the offering become available. Fitch Assigns BBB Rating to Thermo Fisher Scientific €1.6B Senior Notes Offering The rating agency said it expects that the company will use the proceeds from the offering to finance its $4.2 billion acquisition of FEI. Thermo Fisher Scientific Plans Offering of €600M in Senior Notes Fitch has given the two-year senior notes offering a BBB rating with a Stable outlook. PerkinElmer Prices €500M Senior Note Offering The 10-year notes were rated BBB by Fitch, which also declared the ratings outlook Stable. Thermo Fisher Prices $1B of Senior Notes The firm plans to use the proceeds, along with cash on hand, to redeem its outstanding $1 billion senior notes that mature August 15. Apr 4, 2016 Thermo Fisher Senior Notes Offering Rated BBB by Fitch Mar 2, 2016 Fitch Affirms Thermo Fisher Ratings, Stable Outlook Sep 17, 2015 Fitch Upgrades PerkinElmer Debt Rating Apr 22, 2015 Fitch Affirms BBB Rating for Quest Mar 5, 2015 Fitch Assigns BBB Rating to Quest's Senior Notes Offering Nov 10, 2014 Fitch Affirms Bio-Rad Ratings At BBB- Nov 6, 2014 Thermo Fisher Plans $800M Senior Notes Offering; Fitch Issues BBB Rating for Firm's Notes Nov 3, 2014 Fitch Affirms Agilent's Long-term Debt Ratings at BBB+; Company Completes Keysight Spin Off Dec 4, 2013 Fitch Downgrades Thermo Fisher's Issuer Default Rating Nov 22, 2013 In Brief This Week: Bio-Rad; Fitch, Abbott; Gentris; Indiana Biosciences Research Institute; Strand Life Sciences; Oncospire Genomics Sep 19, 2013 Fitch Affirms Agilent Debt Ratings; Revises Outlook to Stable Jun 18, 2013 UPDATE: Agilent to Offer Senior Notes; Fitch Rates Offering BBB+ Apr 16, 2013 Fitch Places Thermo Fisher, Life Tech Ratings on Negative Watch after Announcement of $13.6B Deal Apr 12, 2013 Fitch Affirms BBB+ Rating on Agilent's $2.8B of Debt Feb 25, 2013 Quest Selling HemoCue to Danaher's Radiometer; Fitch Affirms Quest's BBB+ Rating Jan 29, 2013 Fitch Places Life Tech's Ratings on Evolving Watch Following Acquisition Speculation Nov 14, 2012 Bio-Rad Ratings Affirmed by Fitch Sep 21, 2012 Fitch Affirms PerkinElmer Ratings, Saying Outlook is Stable Sep 10, 2012 Agilent Prices Public Offering of Senior Notes at $400M Jul 17, 2012 Fitch Downgrades Thermo Fisher IDR, Senior Secured Ratings to BBB+ Load More Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.